[The actual issues of comparing the results of quantitative immune-enzyme tests].
The analysis was applied to the situation on national market of immune-enzyme diagnosticums with further quantitative reporting of results. The issues of coincidence and interpretation of results and causes of discrepancy are considered The notions of biologic ambiguity and metrological traceability are explained.